Boston Financial Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-55,834	Closed	-$1.31M	–	205
2013 Q3	$1.31M	Buy	55,834 +140	+0.3%	+$3.29K	0.2%	123
2013 Q2	$1.5M	Buy	+55,694	New	+$1.5M	0.23%	113